The body’s main antioxidant tripeptide. It is in 503A Category 1, so compounding is allowed while FDA evaluates it.
Key takeaway
Glutathione is a three-amino-acid molecule that every cell makes. It helps neutralize reactive oxygen species and supports liver detoxification.
At a glance
| FDA status | Not FDA-approved |
|---|---|
| 503A compounding | 503A Category 1: under FDA evaluation, compounding allowed under interim policy |
| Body areas | Cellular energy & aging, Immune & inflammation, Skin & hair |
| Through ScriptMates | Prescribable by licensed providers |
| Open questions | 1 noted below |
What is glutathione?
Glutathione is a three-amino-acid molecule that every cell makes. It helps neutralize reactive oxygen species and supports liver detoxification.
It is not an FDA-approved drug. It is in 503A Category 1, which FDA’s interim policy allows to be compounded while FDA evaluates it.
Dosage forms
No FDA-approved dosage form. FDA lists glutathione as a bulk substance under evaluation, without specifying a finished dosage form. Compounded preparations are not FDA-approved.
Is glutathione FDA-approved?
Not FDA-approved as a drug. In 503A Category 1 (under evaluation).
Can it be prescribed through ScriptMates?
503A Category 1: under FDA evaluation, compounding allowed under interim policy. A 503A partner pharmacy lists this peptide, and it has a lawful 503A compounding pathway.
What we could not confirm
- Glutathione is a small tripeptide and is often classed as an antioxidant rather than a therapeutic peptide. We list it because partner catalogs carry it.
Sources
- FDA: Bulk drug substances nominated under 503A, Categories 1–3 (May 14, 2026)
- FDA: Bulk drug substances used in compounding under section 503A
Checked October 27, 2026. FDA updates these pages, so confirm before relying on them.